These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 8600428)

  • 1. Pupillary response to tropicamide in patients with Alzheimer disease.
    Loupe DN; Newman NJ; Green RC; Lynn MJ; WIlliams KK; Geis TC; Edelhauser HF
    Ophthalmology; 1996 Mar; 103(3):495-503. PubMed ID: 8600428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tropicamide effects on pupil size and pupillary light reflexes in Alzheimer's and Parkinson's disease.
    Granholm E; Morris S; Galasko D; Shults C; Rogers E; Vukov B
    Int J Psychophysiol; 2003 Feb; 47(2):95-115. PubMed ID: 12568941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pupil dilation to tropicamide is not specific for Alzheimer disease.
    Growdon JH; Graefe K; Tennis M; Hayden D; Schoenfeld D; Wray SH
    Arch Neurol; 1997 Jul; 54(7):841-4. PubMed ID: 9236572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Re-evaluation of tropicamide in the pupillary response test for Alzheimer's disease.
    Iijima A; Haida M; Ishikawa N; Ueno A; Minamitani H; Shinohara Y
    Neurobiol Aging; 2003 Oct; 24(6):789-96. PubMed ID: 12927761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Receptor test (pupillary dilatation after application of 0.01% tropicamide solution) and determination of central nervous activation (Fourier analysis of pupillary oscillations) in patients with Alzheimer's disease.
    Grünberger J; Linzmayer L; Walter H; Rainer M; Masching A; Pezawas L; Saletu-Zyhlarz G; Stöhr H; Grünberger M
    Neuropsychobiology; 1999; 40(1):40-6. PubMed ID: 10420100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Response of the pupil to tropicamide is not a reliable test for Alzheimer disease.
    FitzSimon JS; Waring SC; Kokmen E; McLaren JW; Brubaker RF
    Arch Neurol; 1997 Feb; 54(2):155-9. PubMed ID: 9041856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pupillary response to tropicamide in Alzheimer's disease.
    Fridh M; Havelius U; Elofsson G; Hindfelt B
    Acta Ophthalmol Scand; 1996 Jun; 74(3):276-9. PubMed ID: 8828726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pupil response to tropicamide in Alzheimer's disease and other neurodegenerative disorders.
    Gómez-Tortosa E; del Barrio A; Jiménez-Alfaro I
    Acta Neurol Scand; 1996 Aug; 94(2):104-9. PubMed ID: 8891054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Why patients with Alzheimer's disease may show increased sensitivity to tropicamide eye drops: role of locus coeruleus.
    Hou RH; Samuels ER; Raisi M; Langley RW; Szabadi E; Bradshaw CM
    Psychopharmacology (Berl); 2006 Jan; 184(1):95-106. PubMed ID: 16308726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hypersensitivity in the pupil dilation response to a cholinergic antagonist in patients with Alzheimer's disease and Down's syndrome].
    Kono K; Miyao M; Ishihara S; Takagi A; Ikari H; Suzuki Y; Iguchi A
    Nihon Ronen Igakkai Zasshi; 1996 Nov; 33(11):829-34. PubMed ID: 8997102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tropicamide eyedrops cannot be used for reliable diagnosis of Alzheimer's disease.
    Graff-Radford NR; Lin SC; Brazis PW; Bolling JP; Liesegang TJ; Lucas JA; Uitti RJ; O'Brien PC
    Mayo Clin Proc; 1997 Jun; 72(6):495-504. PubMed ID: 9179132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The mydriatic effect of multiple doses of tropicamide.
    Siderov J; Nurse S
    Optom Vis Sci; 2005 Nov; 82(11):955-8. PubMed ID: 16317370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can tropicamide eye drop response differentiate patients with progressive supranuclear palsy and Alzheimer's disease from healthy control subjects?
    Litvan I; FitzGibbon EJ
    Neurology; 1996 Nov; 47(5):1324-6. PubMed ID: 8909451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is videopupillography useful in the diagnosis of Alzheimer's disease?
    Ferrario E; Molaschi M; Villa L; Varetto O; Bogetto C; Nuzzi R
    Neurology; 1998 Mar; 50(3):642-4. PubMed ID: 9521249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of an eye drop mixture for pupillary dilatation: A randomized comparative study.
    Bhurayanontachai P; Saengkaew S; Apiromruck P
    J Optom; 2017; 10(2):111-116. PubMed ID: 27321772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pupil dilatation assay by tropicamide is modulated by apolipoprotein E epsilon 4 allele dosage in Alzheimer's disease.
    Arai H; Terajima M; Nakagawa T; Higuchi S; Mochizuki H; Sasaki H
    Neuroreport; 1996 Mar; 7(4):918-20. PubMed ID: 8724673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Experience with pupil tropicamide test in Alzheimer's disease].
    Robles A; Touriño R; Sesar A; Suárez P; Noya M
    Rev Neurol; 1996 Jan; 24(125):65-8. PubMed ID: 8852002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dapiprazole clinical efficiency for counteracting tropicamide 1%.
    Molinari JF; Johnson ME; Carter J
    Optom Vis Sci; 1994 May; 71(5):319-22. PubMed ID: 7915025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The tropicamide test in patients with dementia of Alzheimer type and frontotemporal dementia.
    Robles A; Touriño R; Gude F; Noya M
    Funct Neurol; 1999; 14(4):203-7. PubMed ID: 10713893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pupillary response to tropicamide in Japanese patients with alcoholic dementia, Alzheimer's disease, and vascular dementia.
    Higuchi S; Matsushita S; Hasegawa Y; Muramatsu T; Arai H
    Exp Neurol; 1997 Mar; 144(1):199-201. PubMed ID: 9126171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.